<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Vertex Pharmaceuticals Inc. | Company News & Executive Profiles - VRTX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Vertex Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="30" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Vertex Pharmaceuticals Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-357016.html]]></link>
		<description><![CDATA[ Question-and-Answer Session(Operator's Instructions) We'll go first to Rachel McMinn with Bank of America-Merrill Lynch. Rachel McMinn - Bank of America-Merrill Lynch  Thank you much for taking the question.  You've mentioned that data from combination studies where telaprevir and 222 could be available by mid-2010.  I know...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 26 Oct 2009 18:23:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/study.html"><![CDATA[Study]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">VRTX</category>
	</item>
	<item>
		<title><![CDATA[Vertex Set to See More Volatility on Hepatitis Drug Data Release]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F158135-vertex-set-to-see-more-volatility-on-hepatitis-drug-data-release%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[optionMONSTER submits:  by David Russell Vertex Pharmaceuticals VRTX is expected to release key data on a new hepatitis C treatment early next year, and one investor is positioning for increased volatility. by optionMONSTER]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 25 Aug 2009 05:01:34 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/optionmonster.html"><![CDATA[optionMONSTER]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">VRTX</category>
	</item>
	<item>
		<title><![CDATA[Vertex: Long Term Buy Opportunity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F140820-vertex-long-term-buy-opportunity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   By: Jason Napodano, CFA Vertex Pharmaceuticals, Inc. VRTX represents an attractive long-term opportunity based on the potential blockbuster sales of telaprevir and its newly established position as the market leader for new HCV treatment options with the closing of the ViroChem deal in March 2009. Also,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 02 Jun 2009 02:41:48 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">VRTX</category>
	</item>
	<item>
		<title><![CDATA[Vertex to Buy Hepatitis C Drug Developer ViroChem for $375 Million]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F124128-vertex-to-buy-hepatitis-c-drug-developer-virochem-for-375-million%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits: Vertex VRTX, which is developing the hepatitis C virus (HCV) protease inhibitor telaprevir, will add two polymerase inhibitors to its HCV drug development portfolio through an agreement to acquire privately-held ViroChem Pharma in a stock and cash transaction. The move expands Vertex&#8217;s global presence in HCV and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 04 Mar 2009 10:36:54 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">VRTX</category>
	</item>
	<item>
		<title><![CDATA[Vertex Pharmaceuticals Incorporated, Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-267349.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions Your first question comes from the line of Rachel McMinn from Cowen & Company. Go ahead. Rachel McMinn - Cowen & Company  Thanks very much. Two questions, one on the financial and may be you can talk a little bit more about...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Feb 2009 16:06:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[Asset]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/business+development.html"><![CDATA[Business Development]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/asset+management.html"><![CDATA[Asset Management]]></category>
		<category domain="http://resources.bnet.com/topic/strategic+planning.html"><![CDATA[Strategic Planning]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/operational+planning.html"><![CDATA[Operational Planning]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">VRTX</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Cache, Inc., WPP Group Plc., Companhia Vale do Rio Doce, Vertex Pharmaceuticals Inc. and Johnson & Johnson]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_29/ai_n30940791]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cache, Inc. (Nasdaq: CACH), WPP Group Plc. (Nasdaq: WPPGY), Companhia Vale...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 29 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[blog]]></category>
		<category domain="http://resources.bnet.com/topic/cache+inc..html"><![CDATA[Cache Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CACH</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">CACH,JNJ,NDAQ,VRTX</category>
	</item>
	<item>
		<title><![CDATA[Vertex Pharmaceuticals Incorporated Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-244198.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. And your first question comes from Rachel McMinn from Cowen & Company. Your line is open. Rachel McMinn - Cowen & Company Thanks very much. To start off with you, Ian, can you give us a better sense of what was in your P&L as...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 27 Oct 2008 19:43:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">VRTX</category>
	</item>
	<item>
		<title><![CDATA[Directors Roster: a quarterly record of new director appointments]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_go2446/is_1_33/ai_n31063035]]></link>
		<description><![CDATA[THE DIRECTOES & BROARDS  Directors Roster--a quarterly record of new director appointments--is compiled from public and private sources by the editorial staff of DIRECTORS & BOARDS and is sponsored by Heidrick & Struggles. Please forward your directors' appointments to kmccarthy@directors-andboards.com.  Submissions of new directors and appointments are welcome...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 22 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cardionet+inc..html"><![CDATA[CARDIONET INC.]]></category>
		<category domain="http://resources.bnet.com/topic/computer+associates+international+inc..html"><![CDATA[Computer Associates International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/deltek+inc..html"><![CDATA[DELTEK INC.]]></category>
		<category domain="http://resources.bnet.com/topic/fannie+mae+washington+dc.html"><![CDATA[FANNIE MAE Washington DC]]></category>
		<category domain="http://resources.bnet.com/topic/firstenergy+corp..html"><![CDATA[FirstEnergy Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/gsi+technology+inc..html"><![CDATA[GSI Technology Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ict+group+inc..html"><![CDATA[ICT GROUP INC.]]></category>
		<category domain="http://resources.bnet.com/topic/kimball+international+inc..html"><![CDATA[Kimball International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/lorillard+inc..html"><![CDATA[LORILLARD INC.]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BEAT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSIT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KBAL B</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">BEAT,FE,GSIT,KBAL B,VRTX</category>
	</item>
	<item>
		<title><![CDATA[Nasdaq 100 Struggles]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F93750-nasdaq-100-struggles%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Hickey and Walters Bespoke submit:   The tech-heavy Nasdaq 100 is currently set to have its third straight -1% decline.  Below we highlight the 25 (out of 100) worst performing stocks in the index since last Thursday's close.  As shown, Dell has lost nearly a fifth of its value...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 03 Sep 2008 10:06:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/dell+computer+corp..html"><![CDATA[Dell Computer Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/chip.html"><![CDATA[Chip]]></category>
		<category domain="http://resources.bnet.com/topic/autodesk+inc..html"><![CDATA[Autodesk Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/akamai+technologies+inc..html"><![CDATA[Akamai Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/altera+corp..html"><![CDATA[Altera Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/applied+materials+inc..html"><![CDATA[Applied Materials Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/broadcom+corp..html"><![CDATA[Broadcom Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/flextronics+international+ltd..html"><![CDATA[Flextronics International Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/flir+systems+inc..html"><![CDATA[FLIR Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/foster+wheeler+ltd..html"><![CDATA[Foster Wheeler Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/hologic+inc..html"><![CDATA[Hologic Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/intel+corp..html"><![CDATA[Intel Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/joy+global+inc..html"><![CDATA[Joy Global Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/kla-tencor+corp..html"><![CDATA[KLA-Tencor Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/linear+technology.html"><![CDATA[Linear Technology]]></category>
		<category domain="http://resources.bnet.com/topic/lam+research.html"><![CDATA[Lam Research]]></category>
		<category domain="http://resources.bnet.com/topic/marvell+technology+group+ltd..html"><![CDATA[Marvell Technology Group Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/nvidia+corp..html"><![CDATA[NVidia Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/oracle+corp..html"><![CDATA[Oracle Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/qualcomm+inc..html"><![CDATA[Qualcomm Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/research+in+motion+ltd..html"><![CDATA[Research In Motion Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/sandisk+corp..html"><![CDATA[SanDisk Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/steel+dynamics+inc..html"><![CDATA[Steel Dynamics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/xilinx+inc..html"><![CDATA[Xilinx Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMAT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BRCM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DELL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FLEX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FLIR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FWLT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JOYG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KLAC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LRCX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVDA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ORCL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">QCOM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNDK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">STLD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XLNX</category>
		<category domain="tickers">AKAM,ALTR,AMAT,ADSK,BRCM,DELL,FLEX,FLIR,FWLT,HOLX,INTC,JOYG,KLAC,LRCX,LLTC,MRVL,NVDA,ORCL,QCOM,RIMM,SNDK,STLD,VRTX,XLNX</category>
	</item>
	<item>
		<title><![CDATA[5 Potential Buyout Targets in Biotech - Barron's]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F91293-5-potential-buyout-targets-in-biotech-barron-s%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Bristol-Myers Squibb BMY made a $4.5B bid for the shares of ImClone IMCL it doesn't already own. Roche Holdings (RHHBY.PK) made a $44B offer for the shares of Genetech DNA it doesn't own. Both targets want the bid prices raised. Barron's Lawrence Strauss says these are just the two latest...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 17 Aug 2008 03:50:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/alexion+pharmaceuticals+inc..html"><![CDATA[Alexion Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/onyx+pharmaceuticals+inc..html"><![CDATA[Onyx Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/united+therapeutics+corp..html"><![CDATA[United Therapeutics Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALXN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ONXX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UTHR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">ALXN,AMLN,BMY,LLY,DNA,IMCL,MRK,ONXX,PFE,UTHR,VRTX,WYE</category>
	</item>
</channel>
</rss>
